Regina Nagle appointed as SVP of Business Development at C2i Genomics – Asaf Zviran

In a post by Asaf Zviran on LinkedIn, it says, “As we continue our strong momentum in biopharma and clinical commercialization, our team at C2i Genomics is excited to welcome Regina Nagle as our Senior Vice President of Business Development!

With 25 years of experience in NGS genomic analysis and a remarkable track record in the biopharma and life science industries, Regina brings her impressive expertise in strategic business development, planning, and corporate execution to our team.

The recent availability of cheap whole genome sequencing creates an opportunity and a challenge for cancer data management and digital diagnostic at an unprecedented scale. Our partners include some of the largest diagnostic, pharma, and healthcare organizations globally.”

Source: Asaf Zviran / LinkedIn